Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
Contenido de curso
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Objetivos de formación
Please see our websie for all the details
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants

Información e inscripción:

Mr. Duane Fowler
no registration fee
Cantacto organizador
3500 Maple Ave. Ste. 700
75219 Dallas
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Alumni Club Medizinische Universität WienÖsterreichisches Rotes KreuzHelix - Forschung & Beratung WienEuropean Health Forum GasteinAMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteCenter of ExcellenceEuropean Public Health Association (EUPHA)